We are developing our drug for
breast, lung, leukemia, melanoma
and other cancers.

What We Do

Armaceutica, Inc. is a privately-held pharmaceutical company
with a focus on treating cancer.

website template image

New cancer drug kills breast cancer, lung cancer, leukemia and melanoma cells.

Our patented, developmental-stage cancer drug is essentially free from serious side effects. It’s a breakthrough because it selectively kills cancer cells over normal, healthy cells and it’s “well tolerated” with “no serious toxicities”. Physicians and patients will prefer it to current, debilitatingchemotherapy.

website template image

New COVID-19 drug inhibits coronavirus and IL-6 associated with cytokine storm.

Our patent-pending, developmental-stage COVID-19 drugmay interfere with signaling pathways including release of IL-6 that lead to the cytokine storm responsible for inflammation and disruption of lung, heart and kidney function, and death of COVID-19 patients.

What Is Happening at Armacetuica?

Our patented, developmental-stage cancer drug is essentially free from serious side effects. It’s a breakthrough because it selectively kills cancer cells over normal, healthy cells and it’s “well tolerated” with “no serious toxicities”. Physicians and patients will prefer it to current, debilitating chemotherapy.

Our goal is to provide cancer patients - in particular children - with a safe and effective treatment that is essentially free from the horrible and debilitating side effects associated with other cancer therapies.

Contact Us!

Powered By Boston SEO Marketing Service